A cost-effectiveness analysis of three PARP inhibitors for maintenance therapy in platinum-sensitive recurrent ovarian cancer
2020 ◽
Vol 159
(2)
◽
pp. 483-490
◽
2007 ◽
Vol 107
(2)
◽
pp. 211-218
◽
2019 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Vol 24
(12)
◽
pp. 1219-1228
◽
Keyword(s):